XML 57 R40.htm IDEA: XBRL DOCUMENT
v3.24.3

Stockholder's Equity (Tables) | 12 Months Ended
--- | ---
Jul. 31, 2024
Equity [Abstract] |
Schedule of Share-Based Compensation Expense | The table below sets forth the stock-based compensation recognized by the Company for stock options, restricted stock, restricted unit awards, and performance stock units:
|  | Year Ended July 31,
(In thousands) |  | 2024 |  | 2023 |  | 2022
General and administrative |  | $ | 28,284 |  |  | $ | 32,747 |  |  | $ | 33,838 |
Yard operations |  | 6,950 |  |  | 6,926 |  |  | 5,127 |
Total stock-based compensation |  | $ | 35,234 |  |  | $ | 39,673 |  |  | $ | 38,965 |
Schedule of Fair Value Assumptions | The BSM option-pricing model utilized the following assumptions:
|  | July 31, |
|  | 2024 |  | 2023 |  | 2022
Expected life (in years) |  | 5.0 |  | — |  | 6.3 |  |  | 5.0 |  | — |  | 6.3 |  |  | 5.1 |  | — |  | 6.8 |
Risk-free interest rate |  | 3.86 |  | % | — |  | 4.43 |  | % |  | 3.67 |  | % | — |  | 3.88 |  | % |  | 0.82 |  | % | — |  | 2.70 |  | %
Estimated volatility |  | 30.1 |  | % | — |  | 30.6 |  | % |  | 29.6 |  | % | — |  | 32.0 |  | % |  | 27.9 |  | % | — |  | 30.0 |  | %
Expected dividends |  | — |  | % |  | — |  | % |  | — |  | %
Weighted average fair value at measurement date |  | $ | 9.93 |  |  |  | $ | 12.10 |  |  |  | $ | 10.59 |  |
Schedule of Unvested Stock Options Awards | A summary of the status of the Company’s unvested stock options awards and activity during the year ended July 31, 2024 was as follows:
(In thousands, except per share amounts) |  | Shares |  | Weighted Average Grant- date Fair Value
Unvested shares at July 31, 2023 |  | 5,770 |  |  | $ | 8.72 |
Grants of non-vested shares |  | 1,121 |  |  | 10.85 |
Vested |  | (2,713) |  |  | 7.93 |
Forfeitures or expirations |  | — |  |  | — |
Unvested shares at July 31, 2024 |  | 4,178 |  |  | $ | 9.80 |
Schedule of Option Activity | The following is a summary of activity for the Company’s stock options for the year ended July 31, 2024:
(In thousands, except per share and term data) |  | Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (In years) |  | Aggregate Intrinsic Value
Outstanding as of July 31, 2023 |  | 17,825 |  |  | $ | 15.47 |  |  | 4.67 |  | $ | 512,045 |
Grants of options |  | 1,046 |  |  | 49.68 |  |  |  |  |
Exercises |  | (2,561) |  |  | 9.47 |  |  |  |  |
Forfeitures or expirations |  | — |  |  | — |  |  |  |  |
Outstanding as of July 31, 2024 |  | 16,310 |  |  | $ | 18.60 |  |  | 4.34 |  | $ | 550,115 |
Exercisable as of July 31, 2024 |  | 13,968 |  |  | $ | 15.41 |  |  | 3.72 |  | $ | 515,734 |
Vested and expected to vest as of July 31, 2024 |  | 16,272 |  |  | $ | 18.59 |  |  | 4.34 |  | $ | 549,123 |
The following is a summary of activity for the Company’s stock option awards subject to market conditions for the year ended July 31, 2024:
(In thousands, except per share and term data) |  | Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (In years) |  | Aggregate Intrinsic Value
Outstanding as of July 31, 2023 |  | 5,920 |  |  | $ | 24.37 |  |  | 7.43 |  | $ | 117,389 |
Grants of options |  | 75 |  |  | 50.89 |  |  |  |  |
Exercises |  | — |  |  | — |  |  |  |  |
Forfeitures or expirations |  | — |  |  | — |  |  |  |  |
Outstanding as of July 31, 2024 |  | 5,995 |  |  | $ | 24.70 |  |  | 6.47 |  | $ | 165,656 |
Exercisable as of July 31, 2024 |  | 4,160 |  |  | $ | 23.23 |  |  | 6.22 |  | $ | 121,072 |
Vested and expected to vest as of July 31, 2024 |  | 5,988 |  |  | $ | 24.70 |  |  | 6.47 |  | $ | 165,464 |
Schedule of Stock Options Outstanding and Exercisable | The following table summarizes stock options outstanding and exercisable as of July 31, 2024:
(In thousands, except per share amounts) |  | Options Outstanding |  | Options Exercisable
Range of Exercise Prices |  | Number |  | Weighted Average Remaining Contractual Life |  | Weighted Average Exercise Price |  | Number |  | Weighted Average Exercise Price
$4.37 | — | $6.98 |  | 2,729 |  |  | 1.42 |  | $ | 5.22 |  |  | 2,730 |  |  | $ | 5.22 |
$7.74 | — | $9.08 |  | 2,713 |  |  | 3.18 |  | 8.85 |  |  | 2,713 |  |  | 8.85 |
$10.99 | — | $21.26 |  | 8,811 |  |  | 4.94 |  | 17.35 |  |  | 8,059 |  |  | 16.99 |
$22.15 | — | $54.93 |  | 8,052 |  |  | 6.66 |  | 32.33 |  |  | 4,626 |  |  | 29.53 |
Outstanding as of July 31, 2024 |  | 22,305 |  |  | 4.91 |  | $ | 20.24 |  |  | 18,128 |  |  | $ | 17.20 |
Schedule of Restricted Stock and Performance Stock Activity | The following is a summary of activity for the Company’s RSAs, RSUs, ans PSUs for the for the year ended July 31, 2024:
(In thousands, except per share data) |  | Restricted and Performance Shares |  | Weighted Average Grant Date Fair Value
Outstanding as of July 31, 2023 |  | 800 |  |  | $ | 31.77 |
Grants |  | 1,479 |  |  | 51.72 |
Vested |  | (391) |  |  | 32.76 |
Forfeitures or expirations |  | (15) |  |  | 34.84 |
Outstanding as of July 31, 2024 |  | 1,873 |  |  | $ | 47.29 |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration